Skip to main content
EarningsCallAI
LLY

Eli Lilly and Company

Healthcare

TAILWIND(HIGH)

Operator Signal: TAILWIND

Revenue growth is accelerating. This company is seeing consistent demand expansion, good signal for adjacent markets.

$19.8B
Latest Revenue
+73.1%
Revenue Growth (YoY)
$8.26
Latest EPS
$7.4B
Latest Net Income

Quarterly Earnings History

QuarterRevenueNet IncomeEPS
Q1 2026$19.8B$7.4B$8.26
Q3 2025$17.6B$5.6B$6.21
Q2 2025$15.6B$5.7B$6.29
Q1 2025$12.7B$2.8B$3.06
Q3 2024$11.4B$970.3M$1.07
Q2 2024$11.3B$3.0B$3.28
Q1 2024$8.8B$2.2B$2.48
Q3 2023$9.5B$-57.4M$-0.06

What This Means for Operators

Eli Lilly and Company is in growth mode. Revenue is trending up quarter-over-quarter, which means the markets they serve are expanding. If you sell into the same ecosystem or serve similar customers, this is a green light.

When LLY grows, they hire, they increase vendor budgets, and their customers have more budget too. Follow the money.

Data from SEC EDGAR. View original filings: Eli Lilly and Company SEC Filings

Frequently Asked Questions

Eli Lilly and Company (LLY) currently has a TAILWIND operator signal with HIGH confidence. This signal is based on quarterly revenue trends and earnings patterns across 8 quarters of data.

Eli Lilly and Company's latest reported revenue is $19.8B, representing +73.1% year-over-year growth. Latest EPS was $8.26.

Based on 8 quarters of earnings data, Eli Lilly and Company shows a TAILWIND signal. Revenue is trending upward, indicating growth.

Eli Lilly and Company's quarterly (10-Q) and annual (10-K) filings are available on SEC EDGAR. We analyze these filings to extract revenue, EPS, and net income data for our operator signal calculations.

Sources: SEC EDGAR
Last updated:

Operator signals are derived from quarterly revenue trends, EPS patterns, and net income direction across multiple quarters. Signals indicate momentum direction, not stock recommendations.